US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 4.3200
  • +0.1300+3.10%
Close Nov 29 13:00 ET
  • 4.4000
  • +0.0800+1.85%
Post 16:29 ET
112.75MMarket Cap-975P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inovio Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
104.50K
0
-104.50K
Miss Est.
-73.10%
-100.00%
-100.00%
EPS
-1.15
-0.89
+0.26
Beat Est.
+26.28%
+41.45%
+22.60%
Analyst Rating
Buy

Nov 30, 2024

Inovio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 30.000K--
Nov 14, 20242024/Q30.000 / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 30.000K--
Nov 14, 20242024/Q30.000 / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--

Unlock Free Earnings Estimates

Inovio Pharmaceuticals Earnings Reports

  • Inovio Pharmaceuticals | 8-K: INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 14 16:11 ET

  • Inovio Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:09 ET

  • Inovio Pharmaceuticals | 8-K: INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 8 17:06 ET

  • Inovio Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Mpox (monkeypox)
    Mpox (monkeypox)
    Intraday+0.54%